A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of alefacept when given in combination with methotrexate in subjects with psoriatic arthritis with an open-label retreatment course

Trial Profile

A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of alefacept when given in combination with methotrexate in subjects with psoriatic arthritis with an open-label retreatment course

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Jun 2015

At a glance

  • Drugs Alefacept (Primary) ; Methotrexate
  • Indications Psoriatic arthritis
  • Focus Therapeutic Use
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 06 May 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top